Does Silicon Valley Hold the Key to a new COPD treatment?
Inflammation is a key driver of many chronic diseases including COPD. The race is on for pharmaceutical companies to come up with molecules which suppress inflammation. But is the race already over and has the Silicon Valley company HVMN come up with a home run? Beta-hydroxybutyrate (βHB) has become the talking point amongst amateur biohackers … Continued